Search company, investor...

Founded Year



Incubator/Accelerator - II | Alive

Total Raised


About Neurocern

Neurocern is an artificial intelligence (AI) and neuroinformatics company. The platform ingests data from sources including electronic health records, prescription data, insurance claims data, and more to drive health outcomes, enterprise performance, and financial return on investment (ROI). It serves health systems, insurers, and life sciences companies. It was founded in 2014 and is based in Chicago, Illinois.

Headquarters Location

171 North Aberdeen Street Suite 4R

Chicago, Illinois, 60607,

United States


Neurocern's Product Videos

Neurocern's Products & Differentiators

    Physician Portal

    Secure cloud-based platform with AI engine provides precise neurological insights for patients with neurological, cognitive, and other medical conditions.


Expert Collections containing Neurocern

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neurocern is included in 1 Expert Collection, including Digital Health.


Digital Health

10,595 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Latest Neurocern News

Neurocern Demonstrates $370M in Savings for Medicare and Health Insurance Using Artificial Intelligence and Data Analytics Targeted at Alzheimer’s Disease Drug Eligibility

Dec 8, 2021

December 08, 2021 09:00 AM Eastern Standard Time CHICAGO--( BUSINESS WIRE )-- Neurocern announced today a savings outcome of $370M over five years by leveraging artificial intelligence (AI) and neuroinformatics to guide patients to the right Alzheimer’s treatment at the right time. As new disease modifying treatments for Alzheimer’s disease continue to emerge, Medicare and private health insurance plans need data-driven methods to screen, identify, and guide patients to appropriate treatment pathways. Using insurance claims and population health data, Neurocern’s AI engine was able to identify eligible patients for new treatments for Alzheimer’s more accurately than a general physician. This data-driven approach reduced time to diagnosis by flagging and routing patients to the best treatment pathway based on U.S. Food and Drug Administration label indications, a triage process that would save insurers more than $370M over five years in claims costs. “AI has the ability to identify and get patients to treatment faster resulting in better clinical outcomes and significant financial savings for Medicare, private health insurers, and the consumer,” said Dr. Anitha Rao, Founder of Neurocern and a practicing board-certified neurologist. Results from the study, “ Bridging the Gap Between Medicine and Insurance: How to Leverage Data, Artificial Intelligence, and Neuroinformatics for Insurance and Financial Risk Management ,” were published in the November 2021 issue of The CAPCO Institute Journal of Financial Transformation, an award-winning publication that is accredited by the American Economic Association. Neurocern presented similar independently validated results from a real-world pilot with Fortune 500 insurance carriers at the Alzheimer’s Association International Conference. “The ability to generate insights from AI to drive appropriate and cost-effective cognitive health care fills an urgent need, given the paucity of trained subspecialists amidst a growing number of at-need patients. Expert systems powered by semantically normalized, complete and timely clinical data could revolutionize neurocognitive care while reducing costs,” said co-author Dr. Paulo Pinho. Dr. Pinho is Medical Director for Innovation at Diameter Health , a health technology company that normalizes and enriches clinical data for data-driven use cases in health and life insurance, among other sectors. About Neurocern Neurocern is a minority female physician-founded, and veteran-owned AI and neuroinformatics company that uses clinical analytics to compute data from multiple structured sources, including electronic health records, prescription data, and insurance claims data for clinical and financial insights. Contacts

Neurocern Frequently Asked Questions (FAQ)

  • When was Neurocern founded?

    Neurocern was founded in 2014.

  • Where is Neurocern's headquarters?

    Neurocern's headquarters is located at 171 North Aberdeen Street, Chicago.

  • What is Neurocern's latest funding round?

    Neurocern's latest funding round is Incubator/Accelerator - II.

  • How much did Neurocern raise?

    Neurocern raised a total of $200K.

  • Who are the investors of Neurocern?

    Investors of Neurocern include Plug and Play Insurtech and 1871.

  • Who are Neurocern's competitors?

    Competitors of Neurocern include Milliman IntelliScript and 1 more.

  • What products does Neurocern offer?

    Neurocern's products include Physician Portal and 4 more.


Compare Neurocern to Competitors

Prealize Logo

Prealize operates a predictive healthcare analytics company. It offers a predictive analytics platform that anticipates when costly care events will occur, helping healthcare providers shift from reactive to proactive healthcare. The company primarily sells to health plans, employers, and providers across the nation. Prealize was formerly known as Cardinal Analytx. It was founded in 2015 and is based in San Francisco, California.

Decode Health Logo
Decode Health

Decode Health is a precision medicine analytics company that fuels collaboration within pharmaceutical, diagnostic, and technology companies. The company leverages its platform and expertise in genomics, clinical data, social determinants of health, and other healthcare data sources, to bring actionable insights into focus quickly. It creates data assets, products, and services that improve patient outcomes and reduce costs. Projects include genomic data creation, biomarker discovery, RNA diagnostics, and broader population health analytics. Decode Health was founded in 2019 and is headquartered in Nashville, Tennessee.

Codoxo Logo

Codoxo uses Artificial intelligence (AI) to help healthcare companies and agencies in order to detect and respond quickly to problems and opportunities to control costs. Its AI can uncover existing problems and detect emerging problems before they add up. Codoxo was formerly known as Fraudscope. The company was founded in 2017 and is based in Duluth, Georgia.

Story Health

Story Health offers a healthcare technology platform. It builds and offers adaptive, virtualized care systems for specialists. Its products include intelligent embedded clinical software tools, virtual patient programs, and analytics that offers home titration, volume management, and therapy evaluation solutions. It was founded in 2020 and is based in Cupertino, California.

Pivot Logo

Pivot is a behavioral change digital health company on a mission to use mobile technology, behavioral science, and clinical expertise. The company combines wearable tech, clinical expertise, personal coaching, and behavioral science to help people quit smoking. It was founded in 2015 and is based in Redwood City, California.


Retrace is a company focused on streamlining the payment process in the oral health care sector. The company offers a comprehensive billing and office solution that enables oral health care providers to receive payments instantly and accurately. This solution also connects providers, patients, and payers, simplifying administrative tasks and improving the overall patient experience. Retrace primarily serves the healthcare industry, specifically targeting oral health care providers, payers, and patients. It was founded in 2016 and is based in San Francisco, California.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.